As expected, shMRPS23 colocalized with p53 (Figure 3A), and the mRNA and protein expression levels of p53 dramatically increased by 1.5–4 fold in shMRPS23-treated tumours (p < 0.05) (Figure 3B). Here, TP53 is linked to neoplasm.